Loading
Total declarations
Companies
▲ Purchases (13 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Apr 2019 for CASI Pharmaceuticals, Inc., €4.5M.
Filing timeline
BuySaleSpectrum Pharmaceuticals Inc
Insider track record
Disclosed buys
13
Disclosed sells
0
Signal history
Closed purchases
Market purchases
13
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Spectrum Pharmaceuticals Inc: trading record in brief
Spectrum Pharmaceuticals Inc is a declared insider at 2 companies; the most frequent names are CASI Pharmaceuticals, Inc. and Allos Therapeutics Inc. In total, 14 filings cover trades dated from 5 September 2012 to 2 April 2019.
Every open-market trade on record is a purchase: 13 purchases worth €189.0M, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Half of the purchases are above €5,159 and half below. On 8 out of 12 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The record was last updated on 4 April 2019 with a transaction (€4.5M) in CASI Pharmaceuticals, Inc. The last purchase on record was published on 22 December 2017, which is 3,228 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Spectrum Pharmaceuticals Inc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
1,500,000 shares@ US$3.3828100.0% of flowCommon StockSEC:0001209191-19-023751:0
907,356 shares@ US$0.010.2% of flowCommon StockSEC:0001209191-17-067043:0
Canonical exit: 22 Mar 2018 (T+90)
611,740 shares@ US$0.010.1% of flowCommon StockSEC:0001209191-17-067043:1
Canonical exit: 22 Mar 2018 (T+90)
773,790 shares@ US$0.010.2% of flowCommon StockSEC:0001209191-16-147721:0
Canonical exit: 26 Jan 2017 (T+90)
294,815 shares@ US$0.010.1% of flowCommon StockSEC:0001209191-16-147721:1
Canonical exit: 26 Jan 2017 (T+90)
521,692 shares@ US$0.010.1% of flowCommon StockSEC:0001209191-16-147721:2
Canonical exit: 26 Jan 2017 (T+90)
198,765 shares@ US$0.010.0% of flowCommon StockSEC:0001209191-16-147721:3
Canonical exit: 26 Jan 2017 (T+90)
585,790 shares@ US$0.010.1% of flowCommon StockSEC:0001209191-16-137368:0
Canonical exit: 12 Oct 2016 (T+90)
98,271 shares@ US$0.010.0% of flowCommon StockSEC:0001209191-16-137368:1
Canonical exit: 18 Oct 2016 (T+90)
394,942 shares@ US$0.010.1% of flowCommon StockSEC:0001209191-16-137368:2
Canonical exit: 12 Oct 2016 (T+90)
66,255 shares@ US$0.010.0% of flowCommon StockSEC:0001209191-16-137368:3
Canonical exit: 18 Oct 2016 (T+90)
1,008,764 shares@ US$0.010.2% of flowCommon StockSEC:0001209191-16-107987:0
Canonical exit: 22 May 2016 (T+90)
680,113 shares@ US$0.010.1% of flowCommon StockSEC:0001209191-16-107987:1
Canonical exit: 22 May 2016 (T+90)
130,854,840 shares@ US$1.82Common StockSEC:0001181431-12-049057:0
Canonical exit: 4 Dec 2012 (T+90)
14 of 14 declarations
